Patents by Inventor Flordeliza Melchor-Khan

Flordeliza Melchor-Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9974792
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Grant
    Filed: May 24, 2017
    Date of Patent: May 22, 2018
    Assignee: Gilead Sciences, Inc.
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Publication number: 20170258804
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Application
    Filed: May 24, 2017
    Publication date: September 14, 2017
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Patent number: 9687492
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Grant
    Filed: December 3, 2014
    Date of Patent: June 27, 2017
    Assignee: Gilead Sciences, Inc.
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy
  • Publication number: 20150150881
    Abstract: Disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I: or a pharmaceutically acceptable salt thereof. The subject may be very high risk or high risk for the cancer. The subject who has the cancer may also be refractory to at least one chemotherapy treatment, or is in relapse after treatment with chemotherapy, or both. The cancer may be a hematologic malignancy, such as leukemia or lymphoma.
    Type: Application
    Filed: December 3, 2014
    Publication date: June 4, 2015
    Inventors: Julie Di Paolo, Michael J. Hawkins, Jing Hu, Feng Jin, Flordeliza Melchor-Khan, Anita Reddy